Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDR1 | Q08345 | 2/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.47 |
| ▸ | MRGPRX4 | Q96LA9 | 4/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | MLYCD | O95822 | 1/20 | 0.44 |
| ▸ | VNN1 | O95497 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | TMPRSS4 | Q9NRS4 | 1/20 | 0.43 |
| ▸ | KIF11 | P52732 | 1/20 | 0.42 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8208248 | 0.79 | GAA (0.56) | RXFP1GAATMPRSS4 | |
| SCHEMBL7744114 | 0.74 | KIF11 (0.39) | RXFP1MRGPRX4MLYCDVNN1TMPRSS4 | |
| SCHEMBL7744112 | 0.74 | KIF11 (0.39) | RXFP1MRGPRX4MLYCDVNN1TMPRSS4 | |
| SCHEMBL26225890 | 0.74 | DDR1 (0.49) | DDR1RXFP1MRGPRX4GAAMLYCD | |
| SCHEMBL7736234 | 0.73 | RAPGEF3 (0.38) | DDR1RXFP1MRGPRX4MLYCDVNN1 | |
| SCHEMBL7736233 | 0.73 | RAPGEF3 (0.38) | DDR1RXFP1MRGPRX4MLYCDVNN1 | |
| SCHEMBL26227590 | 0.72 | CYP1A2 (0.55) | DDR1RXFP1GAATRPA1 | |
| SCHEMBL26229218 | 0.72 | DDR1 (0.47) | DDR1RXFP1MRGPRX4GAATMPRSS4 | |
| SCHEMBL26229217 | 0.72 | DDR1 (0.67) | DDR1RXFP1GAATMPRSS4TRPA1 | |
| SCHEMBL26229219 | 0.71 | DDR1 (0.46) | DDR1GAATRPA1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6417386-B2 | HYDRAZONE DERIVATIVES; ACARINA; MITICIDES | SYNGENTA CROP PROTECTION, INC. | 2002-07-09 | — | — | US | disclosed |
| US-20010039247-A1 | Pesticidal compositions | KARRER FRIEDRICH (CH) | 2001-11-08 | — | — | US | disclosed |
| US-6306798-B1 | Compounds for controlling insects and representatives of the order acarina | SYNGENTA CROP PROTECTION, INC. | 2001-10-23 | — | — | US | disclosed |
| EP-1021398-A1 | PESTICIDAL COMPOSITIONS | Novartis AG (CH) | 2000-07-26 | — | — | EP | disclosed |
| WO-1998003475-A1 | PESTICIDAL COMPOSITIONS | NOVARTIS AG (CH) | 1998-01-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010039247-A1 | Pesticidal compositions | MTX1, PEF1, ECH1 | DDR1 4414/4885RXFP1 584/4885MRGPRX4 2819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.